Filter
1864
Text search:
drug
trial
Featured
Recommendations
178
New Publications
320
Language
Document type
No document type
1057
Guidelines
315
Studies & Reports
313
Manuals
80
Strategic & Response Plan
30
Fact sheets
30
Training Material
17
Situation Updates
9
Infographics
5
Resource Platforms
4
Brochures
3
App
1
Countries / Regions
India
95
Global
72
South Africa
55
Western and Central Europe
40
Kenya
29
Africa
29
Uganda
27
Ethiopia
25
Russia
23
Tanzania
22
Eastern Europe
22
Nigeria
21
Zambia
21
Liberia
20
Ukraine
19
Sierra Leone
17
Zimbabwe
17
Latin America and the Carribbean
17
Ghana
15
Nepal
15
Malawi
15
Philippines
14
Bangladesh
13
Rwanda
12
Brazil
12
Myanmar / Burma
11
Colombia
9
South–East Asia Region
9
South Sudan
8
Cambodia
8
Mozambique
8
Namibia
8
East and Southern Africa
8
Asia
8
Germany
7
Indonesia
7
Lesotho
7
West and Central Africa
7
Congo, Democratic Republic of
6
USA
6
Thailand
6
Middle East and North Africa
5
Tajikistan
5
Guinea
4
Argentina
4
Eswatini/ Swaziland
4
Vietnam
4
Senegal
3
Cameroon
3
Syria
3
Sudan
3
Angola
3
Yemen
3
Paraguay
3
Venezuela
3
Laos
3
Georgia
3
Burkina Faso
2
Guinea-Bissau
2
Haiti
2
China
2
North Macedonia
2
Hungary
2
Botswana
2
Bolivia
2
Mexico
2
Sri Lanka
2
Eastern Europe and Central Asia
2
Poland
2
Kyrgyzstan
2
Jamaica
2
Spain
2
Belarus
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Somalia
1
Pakistan
1
Jordan
1
Lebanon
1
Gambia
1
Singapore
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Peru
1
Ecuador
1
Bhutan
1
Armenia
1
Southern Africa
1
Timor Leste/ East Timor
1
Qatar
1
Lithuania
1
Iran
1
Kazakhstan
1
North America
1
Belgium
1
France
1
United Kingdom
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
463
Clinical Guidelines
248
Public Health
92
Women & Child Health
81
Key Resources
26
Pharmacy & Technologies
18
Capacity Building
11
Toolboxes
HIV
285
Mental Health
273
TB
221
COVID-19
127
NTDs
119
NCDs
62
Ebola & Marburg
44
AMR
42
Pharmacy
40
Malaria
39
Caregiver
21
Disability
18
Refugee
18
Planetary Health
15
Rapid Response
12
Health Financing Toolbox
12
Global Health Education
9
Cholera
6
Polio
6
2.0 Rapid Response
6
Conflict
5
Natural Hazards
4
Zika
4
Specific Hazards
3
Social Ethics
3
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra
...
Framework for implementation.
The END TB Strategy.
Q9. In adults and children with convulsive epilepsy in remission, when should treatment be discontinued?
Topics in Antiviral Medicine, March 4, 2025
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
Lancet Infect Dis 2020 Published Online May 5, 2020 https://doi.org/10.1016/ S1473-3099(20)30254-1
Policy brief. July 2020
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention an
...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
Issue Brief 8th edition.
2nd edition
Perspectives on drugs
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants
...